Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.281
Abstract: This report describes phase 1 clinical trials performed to assess interactions of oral isavuconazole at the clinically targeted dose (200 mg, administered as isavuconazonium sulfate 372 mg, 3 times a day for 2 days; 200…
read more here.
Keywords:
auc reduced;
methadone;
auc;
substrates bupropion ... See more keywords